Veterans Health Administration Novel Therapeutics Preparedness Act

Improved Access to Emerging Treatments: The Office of Novel Therapeutics will develop guidance to ensure that patient eligibility and management requirements do not unduly restrict access to emerging therapies when they are clinically appropriate (Section 7392(d)(3)).

Enhanced Care Models: The bill directs the development of a national clinical model that includes structured preparation, monitored administration, and post-administration integration to better handle intensive therapeutic interventions (Section 7392(d)(2)).

Structured Support Services: The Office will develop guidance to ensure continuity of care, which includes post-administration integration services, the use of peer support specialists, and coordination with community-based organizations (Section 7392(d)(10)).

Veteran Involvement in Care Design: The creation of a Veteran Advisory Committee allows veterans with lived experience and their family members to provide direct input on patient safety, informed consent, and patient-centered care design (Section 7395(b)-(c)).

Targeted Treatment for Specific Conditions: The Clinical Implementation Program may prioritize several conditions including post-traumatic stress disorder, treatment-resistant depression, substance use disorders, and suicidal behavior (Section 7393(c)).

Potential Safety Risks: The bill acknowledges that without centralized governance, the Department may face safety risks regarding the administration of emerging therapies (Section 2(4)).

Implementation Barriers: The Secretary must report on various potential barriers to implementation, including needs regarding staffing, procurement, and infrastructure (Section 7397(a)(5)).